Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Stomach Neoplasms × Sufentanil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3 Pain 3 Carcinoma, Hepatocellular 3 Pain, Postoperative 2 Lung Neoplasms 2 Inflammation 2 Stomach Neoplasms 1 Postoperative Nausea and Vomiting 1 Pancreatic Neoplasms 1 Neuroma, Acoustic 1 Melanoma 1 Gynecological Laparoscopic Surgery 1 Emergence Delirium 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1

Interventions

Oxaliplatin 249 Capecitabine 172 Fluorouracil 161 Cisplatin 135 Docetaxel 119 S 1 (combination) 113 Leucovorin 107 Paclitaxel 103 Irinotecan 94 pembrolizumab 80 Trastuzumab 54 apatinib 53 Nivolumab 45 Drug Therapy 38 sintilimab 35 Bevacizumab 34 Surgical Procedures, Operative 33 Radiotherapy 33 Ramucirumab 30 Epirubicin 27 titanium silicide 26 tislelizumab 26 Hyperthermic Intraperitoneal Chemotherapy 25 Carboplatin 25 Cyclophosphamide 24 XELOX 23 Tegafur 19 Folfox protocol 19 Cetuximab 19 camrelizumab 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05596071 2022-10-27

POD

Zhejiang Cancer Hospital

Phase NA Completed

Gastrointestinal

Emergence Delirium, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡